TMC Life Sciences Q4 Earnings Up 56%


TMC Life Sciences (TMCLS) Bhd has recorded a strong earnings before interest, taxes, depreciation, and amortisation (EBITDA) growth of 33% from the preceding quarter.

On a year-on-year basis, its Q4 EBITDA rose 56% from FY2017. The strong Q4 performance propelled the group’s full-year revenue, EBITDA and adjusted net profit to growth of 11%, 24% and 31% respectively. The higher earnings were due to to higher patient load, higher intensity of medical and surgical cases handled, and greater operational efficiency and cost management.

TMCLS Executive Director and Group Chief Executive Officer, Roy Quek, said: “We have entered an exciting phase for TMC Life Sciences with the rebranding of our flagship hospital and the completion of our piling works for the expansion of the hospital.”

“The Group continues to record strong growth in our underlying medical and health services, driven by our strong group of clinicians and dedicated staff. With expansion works on track and exciting new partnerships in areas like fertility, we have much to look forward to in the coming years.”

TMCLS’s flagship hospital Thomson Hospital Kota Damansara (THKD) continues to grow the range of tertiary medical services on offer as more consultants were recruited, covering new areas of specialty including Cardiovascular and Thoracic Surgery, Intensive Care, Haematology, Clinical Microbiology and Radiology (Breast Imaging).

In line with THKD’s mission to provide additional tertiary-level services to patients, the hospital has also successfully obtained the licence to operate its own Cytotoxic Drug Reconstitution Laboratory and Yellow Fever Vaccination Centre. By bringing the drug reconstitution service under its roof, patients and doctors now have better access to chemotherapy drugs.

The Group’s multi award-winning and internationally renowned TMC Fertility Centre has also once again broke its previous record of 3,210 IVF babies this year as they celebrated the success of the Highest Number of IVF Babies Produced by A Single Practice with 5,388 IVF babies.

TMCLS expects to award the contract for and start piling work on its Thomson Iskandar Medical Hub project in Johor Bahru before end 2018. The proposed 500-bed tertiary hospital and adjacent commercial tower will significantly increase the group’s overall bed capacity in a key strategic location in Malaysia’s new southern medical hub in Johor.


About Author

Comments are closed.